A. Singanayagam (London, United Kingdom), E. Mortensen (Simsbury, United States of America), C. Cilloniz Campos (Barcelona, Spain), B. Webb (Murray, United States of America)
Community-acquired pneumonia (CAP) with cytomegaloviral (CMV) persistence at young adults: prevalence and reciprocal burdening
K. Chichirelo-Konstantynovych (Vinnytsya, Ukraine), T. Konstantynovych (Vinnytsya, Ukraine), L. Moroz (Vinnytsya, Ukraine)
|   |
Verifying the antibiotic selection algorithm in the new Japanese pneumonia guidelines - Is algorithm-discordant treatment associated with increased mortality of healthcare-associated pneumonia?
M. Aoshima (Kamogawa, Japan), K. Nakashima (Kamogawa, Japan), M. Yaegashi (Kamogawa, Japan), . Shiraishi (Kamogawa, Japan)
| |
Twenty-year Trend in Mortality among Hospitalized Patients with Pneumococcal Community-Acquired Pneumonia
C. Cilloniz Campos (Barcelona, Spain), A. Liapikou (Athens, Greece), I. Martin-Loeches (Dublin, Ireland), C. Garcia-Vidal (Barcelona, Spain), A. Gabarrus (Barcelona, Spain), A. Ceccato (Barcelona, Spain), J. Mensa (Barcelona, Spain), F. Marco (Barcelona, Spain)
| |
Effectiveness of a 23-valent pneumococcal polysaccharide vaccine and a 13-valent pneumococcal conjugate vaccine among the elderly with chronic respiratory diseases
T. Masuda (Shizuoka, Japan), T. Akamatsu (Shizuoka, Japan), E. Nakatani (Osaka, Japan), K. Tamura (Shizuoka, Japan), S. Takahashi (Shizuoka, Japan), Y. Tanaka (Shizuoka, Japan), H. Watanabe (Shizuoka, Japan), Y. Endo (Shizuoka, Japan), T. Suzuki (Shizuoka, Japan), R. Noguchi (Shizuoka, Japan), M. Saigusa (Shizuoka, Japan), A. Yamamoto (Shizuoka, Japan), Y. Shishido (Shizuoka, Japan), T. Akita (Shizuoka, Japan), S. Morita (Shizuoka, Japan), K. Asada (Shizuoka, Japan), T. Shirai (Shizuoka, Japan)
| |
Clinical significance of virus detected community-acquired pneumonia in adults
M. Kim (Daegu, Republic of Korea), W. Choi (Daegu, Republic of Korea), H. Kim (Daegu, Republic of Korea), S. Park (Daegu, Republic of Korea), J. Park (Daegu, Republic of Korea), C. Lee (Andong, Republic of Korea)
| |
Uncommon accumulation of multidrug resistance and virulence potential in carbapenemase ST-14 KPC-3 Klebsiella pneumoniae in Portugal: a high risk threat
C. Gabriel Caneiras (Lisboa, Portugal), J. Melo Cristino (Lisboa, Portugal), L. Lito (Lisboa, Portugal), S. Mayoralas-Alises (Lisboa, Portugal), A. Duarte (Lisboa, Portugal)
| |
Hospitalized community-acquired pneumonia in the elderly: etiology and comorbidities
V. Calancea (Chisinau, Republic of Moldova), S. Matcovschi (Chisinau, Republic of Moldova), T. Dumitras (Chisinau, Republic of Moldova), I. Romaniuc (Chisinau, Republic of Moldova), M. Lupan (Chisinau, Republic of Moldova), D. Fetco-Mereuta (Chisinau, Republic of Moldova), N. Chicu (Chisinau, Republic of Moldova)
| |
RISK FACTORS FOR LONG-TERM MORTALITY IN PATIENTS WITH PNEUMOCOCCAL COMMUNITY-ACQUIRED PNEUMONIA
L. Ruiz Iturriaga (Barakaldo, Spain), L. Serrano Fernandez (Barakaldo, Spain), L. Martinez-Indart (Barakaldo, Spain), A. Gomez Bonilla (Barakaldo, Spain), A. Artaraz Ereño (Galdakao, Spain), B. Gonzalez Quero (Barakaldo, Spain), A. Aramburu Ojembarrena (Galdakao, Spain), P. España Yandiola (Galdakao, Spain), R. Zalacain Jorge (Barakaldo, Spain)
| |
Inhaled antibiotics, pneumonia and bacterial resistance in the ICU
L. Palmer (Stony Brook, NY, United States of America), G. Smaldone (Stony Brook, NY, United States of America)
| |
Platelet activation is boosted early in community-acquired pneumonia and sustained until 30 days later
R. Méndez (Valencia, Spain), A. Moscardó (Valencia, Spain), A. Latorre (Valencia, Spain), A. Piró (Valencia, Spain), I. Amara-Elori (Valencia, Spain), A. Gimeno (Valencia, Spain), P. González (Valencia, Spain), L. Feced (Valencia, Spain), M. Climent (Valencia, Spain), R. Menéndez (Valencia, Spain)
| |
MACROLIDE RESISTANCE HAS A PROGNOSTIC IMPACT IN BACTEREMIC PNEUMOCOCCAL PNEUMONIA
F. Sanz Herrero (València, Spain), E. Fernández-Fabrellas (València, Spain), N. Tormo (València, Spain), R. Guna (València, Spain), C. Gimeno (València, Spain), J. Blanquer (València, Spain)
| |
PREDICTING THE MORTALITY OF PNEUMONIA PATIENTS VISITING THE EMERGENCY DEMARTMENT THROUGH MACHINE LEARNING
Y. BAE (Seoul, Republic of Korea), H. Moon (Seoul, Republic of Korea), S. Kim (Seoul, Republic of Korea)
| |
Carbapenem-resistance pathogens in HAP/VAP patients in US hospitals between 2010 and 2015
B. Cai (Florham Park, NJ, United States of America), R. Echols (Easton, CT, United States of America), F. Corvino (Hoboken, NJ, United States of America), D. Rudin (Florham Park, NJ, United States of America), G. Morgan (Florham Park, NJ, United States of America), Y. Matsunaga (Florham Park, NJ, United States of America), M. Ariyasu (Osaka, Japan), T. Sawada (Osaka, Japan), T. Nagata (Osaka, Japan)
| |
Effects of probiotic supplementation on procalcitonin level and clinical improvements in patients with pneumonia
R. Reviono (Surakarta, Indonesia), S. Yusup (Surakarta, Indonesia), H. Harsini (Surakarta, Indonesia), H. Nugroho (Surakarta, Indonesia)
| |
INCIDENCE AND RISK FACTORS FOR NEW ATRIAL ARRHYTMIA IN PNEUMOCOCCAL PNEUMONIA
L. Serrano Fernandez (Barakaldo, Spain), L. Ruiz Iturriaga (Barakaldo, Spain), L. Martinez-Indart (Barakaldo, Spain), B. Gonzalez Quero (Barakaldo, Spain), A. Artaraz Ereño (Galdakao, Spain), A. Aramburu Ojembarrena (Galdakao, Spain), A. Gomez Bonilla (Barakaldo, Spain), P. España Yandiola (Galdakao, Spain), R. Zalacain Jorge (Barakaldo, Spain)
| |
Association of metformin and mortality for patients with diabetes who are hospitalized with pneumonia
E. Mortensen (Farmington, United States of America), A. Anzueto (San Antonio, United States of America)
| |
Recovery in adults hospitalised with community-acquired pneumonia; a systematic review and meta-analysis
H. Pick (NOTTINGHAM, United Kingdom), C. Bolton (NOTTINGHAM, United Kingdom), W. Lim (NOTTINGHAM, United Kingdom), T. Mckeever (NOTTINGHAM, United Kingdom)
| |
Effect of Oral Chlorhexidine in Preventing Hospital-Acquired Pneumonia among non-intubated patients in the Philippines
m. ogbac (Makati, Philippines), J. Arquiza (Makati, Philippines)
| |
Risk factors of nosocomial pneumonia in multiple trauma patients
M. Kahloul (Sousse, Tunisia), C. Jebali (Sousse, Tunisia), R. Chrigui (Sousse, Tunisia), S. Aissa (Sousse, Tunisia), S. Chouchane (Sousse, Tunisia), M. Chaabani (Sousse, Tunisia), M. Nakhli (Sousse, Tunisia), W. Naija (Sousse, Tunisia)
| |
Optimizing treatment for community-acquired pneumonia in Denmark (The optiCAP study)
M. Fally (Hellerup, Denmark), J. Anhoej (Copenhagen, Denmark), L. Clausen (Hilleroed, Denmark), B. Tarp (Silkeborg, Denmark), T. Benfield (Hvidovre, Denmark), P. Ravn (Hellerup, Denmark)
| |